FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

Source: arsTechnica November 10, 2026 · 06:43
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
From the publisher
The risk appears small and data is mixed, but FDA wants patients to be aware.
About the source

Ars Technica

Ars Technica is a website covering news and opinions in technology, science, politics, and society, created by Ken Fisher and Jon Stokes in 1998. It publishes news, reviews, and guides on issues such as computer hardware and software, science, technology policy, and video games.

Wikipedia
Wikidata Q584152
Wikidata ↗

The original article opens on the publisher's website.

More from General

View topic →